Overview
Availability
- Associate Professor David Macfarlane is:
- Available for supervision
Works
Search Professor David Macfarlane’s works on UQ eSpace
2009
Journal Article
Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers
Herbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536
2009
Journal Article
Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis
Francesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6
2009
Journal Article
Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial
Macfarlane, David, Socrates, Angelides, Eisenberg, Paul, Larcos, George, Roach, Paul, Gerometta, Michael, Smart, Richard, Tsui, Wendy and Scott, Andrew M. (2009). Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging, 36 (2), 250-259. doi: 10.1007/s00259-008-0934-7
2006
Journal Article
Metastatic paraganglioma with extensive bone marrow involvement
Morris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x
2006
Journal Article
Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '
Macfarlane, David J., Smart, Richard C., Tsui, Wendy W., Gerometta, Michael, Eisenberg, Paul R. and Scott, Andrew M. (2006). Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6), 648-656. doi: 10.1007/s00259-005-0025-y
2005
Journal Article
Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen
Kennedy, G. A., Durrant, S., Butler, J., Morton, J., Western, R., Bartlett, M. L., Allison, R. and MacFarlane, D. J. (2005). Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen. Leukemia, 19 (5), 879-880. doi: 10.1038/sj.leu.2403698
2004
Journal Article
Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
Nieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004). Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 (2), 383-389. doi: 10.1182/blood-2003-04-1155
2002
Journal Article
Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies
Bartlett, Marissa L, Webb, Myles, Durrant, Simon, Morton, A James, Allison, Roger and Macfarlane, David J (2002). Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies. European Journal of Nuclear Medicine and Molecular Imaging, 29 (11), 1470-1477. doi: 10.1007/s00259-002-0934-y
2002
Journal Article
153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies
Macfarlane, D. J., Durrant, S., Bartlett, M. L., Allison, R. and Morton, A. J. (2002). 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear medicine communications, 23 (11), 1099-1106. doi: 10.1097/00006231-200211000-00010
2002
Journal Article
Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies
Macfarlane, DJ, Durrant, S, Bartlett, ML, Allison, R and Morton, AJ (2002). Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear Medicine Communications, 23 (11), 1099-1106. doi: 10.1097/01.mnm.0000040978.43128.ae
2002
Journal Article
Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry
Bartlettt, ML and Macfarlane, DJ (2002). Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry. Nuclear Medicine Communications, 23 (8), 743-748. doi: 10.1097/00006231-200208000-00007
2001
Conference Publication
Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.
Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group.
2000
Journal Article
'Liver tail' pseudospleen appearance in denatured erythrocyte scintigraphy with computed tomographic and magnetic resonance correlations
Bakar, K. A., MacFarlane, D., Fong, W. and McEwan, L. (2000). 'Liver tail' pseudospleen appearance in denatured erythrocyte scintigraphy with computed tomographic and magnetic resonance correlations. Clinical Nuclear Medicine, 25 (9), 740-742. doi: 10.1097/00003072-200009000-00026
1999
Journal Article
Strontium and samarium therapy for bone metastases from prostate carcinoma
Dickie, Graeme J. and Macfarlane, David (1999). Strontium and samarium therapy for bone metastases from prostate carcinoma. Australasian radiology, 43 (4), 476-479. doi: 10.1046/j.1440-1673.1999.00716.x
1999
Journal Article
Strontium and samarium therapy for bone metastases from prostate carcinoma
Dickie, G. and Macfarlane, D. (1999). Strontium and samarium therapy for bone metastases from prostate carcinoma. Radiation Oncology, 43 (4), 476-479.
1998
Journal Article
Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience
Wahl, R. L., Zasadny, K. R., MacFarlane, D., Francis, I. R., Ross, C. W., Estes, J., Fisher, S., Regan, D., Kroll, S. and Kaminski, M. S. (1998). Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience. The Journal of Nuclear Medicine, 39 (8 Suppl), 21S-27S.
1998
Journal Article
Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma
Macfarlane, D. J., Sondak, V., Johnson, T. and Wahl, R. L. (1998). Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. Journal of Clinical Oncology, 16 (5), 1770-1776. doi: 10.1200/JCO.1998.16.5.1770
1998
Journal Article
Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma
Macfarlane, DJ, Sondak, V, Johnson, T and Wahl, RL (1998). Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. Journal of Clinical Oncology, 16 (5), 1770-1776.
1998
Conference Publication
Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience
Wahl, RL, Zasadny, KR, MacFarlane, D, Francis, IR, Ross, CW, Estes, J, Fisher, S, Regan, D, Kroll, S and Kaminski, MS (1998). Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience. Symposium on B1 Therapy in Non-Hodgkins Lymphoma - Dosimetry and Clinical Implications, San Antonio Texas, Jun 01, 1997.
1997
Conference Publication
Venoconstriction is impaired during volume unloading in chronic heart failure
Atherton, J., Thomson, H. L., Macfarlane, D., Fong, W., Moore, T., Wright, K., Muehle, G., Fitzpatrick, L. and Frenneaux, M. (1997). Venoconstriction is impaired during volume unloading in chronic heart failure. 3rd International Congress of Nuclear Cardiology, Florence, Italy, April 1997. Journal of Nuclear Cardiology: Springer. doi: 10.1016/S1071-3581(97)91237-X
Funding
Past funding
Supervision
Availability
- Associate Professor David Macfarlane is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Associate Professor David Macfarlane's areas of expertise, story ideas and help finding experts, contact our Media team: